Efficacy and safety of hydrochloridememantine or donepezil combined with risperidone in treatment of Alzheimer′s disease patients with behavioral and psychological symptoms
10.3760/cma.j.cn114798-20210112-00042
- VernacularTitle:盐酸美金刚、多奈哌齐分别联合利培酮治疗阿尔茨海默病伴精神行为症状患者的疗效观察
- Author:
Ruobing QI
1
;
Mingfen SONG
;
Binhua CHEN
;
Yongxiu YANG
;
Xiaowen YIN
;
Xueping ZHANG
Author Information
1. 杭州市第七人民医院老年科 310013
- Keywords:
Alzheimer disease;
Neurobehavioral manifestations;
Psychotropic drugs;
Hydrochloridememantine;
Donepezil
- From:
Chinese Journal of General Practitioners
2021;20(7):777-780
- CountryChina
- Language:Chinese
-
Abstract:
One hundred Alzheimer′s disease (AD) patients with behavioral and psychological symptoms of dementia (BPSD) treated with donepezil+risperidone group ( n=50, group 1) or hydrochloride memantine+risperidone group ( n=50, group 2) in geriatric departments of Hangzhou Seventh People′s Hospital were enrolled in the study. Montreal cognitive assessment scale (MoCA), positive and negative syndrome scale (PANSS), treatment emergent symptom scale (TESS) were applied for evaluation; and blood routine examination, blood biochemistry, eletrocardiogram were performed in two groups before and after treatment. After treatment, MoCA score in group 2 (16.10±3.90) was significantly higher than that in group 1 (18.14±3.71)( t=-3.99, P<0.01), and PANSS score in group 2 (86.66±6.62) was significantly lower than that in group 1 (109.50±11.51; t=12.67, P<0.01). The incidence rates of dry mouth (16%,8/50), extrapyramidal side effects (10%,5/50) and the total score of TESS (3.92±2.02) in group 2 were markedly lower than those of group 1 [44%(22/50), 36%(18/50), (12.49±1.45);χ 2=9.33,9.54, t=17.90,all P<0.01]. Meanwhile, group 2 had significantly lower influences on the levels of blood lipids and fasting blood glucose (all P<0.01). The risperidone dose used in group 2 was significantly lower than that in group 1 [(2.06±0.50) vs. (3.85±0.89)mg, t=14.40, P=0.04].The results suggest that hydrochloridememantine combined with risperidone is more effective with less side effects compared to donepezil combined with risperidone for AD patients with BPSD.
